Literature DB >> 12057007

Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.

Zhiyuan Yu1, Wenzheng Zhang, Bruce C Kone.   

Abstract

Prolific generation of NO by inducible nitric oxide synthase (iNOS) can cause unintended injury to host cells during glomerulonephritis and other inflammatory diseases. While much is known about the mechanisms of iNOS induction, few transcriptional repressors have been found. We explored the role of signal transducers and activators of transcription 3 (STAT3) proteins in interleukin (IL)-1beta- and lipopolysaccharide (LPS)+interferon (IFN)-gamma-mediated iNOS induction in murine mesangial cells. Both stimuli induced rapid phosphorylation of STAT3 and sequence-specific STAT3 DNA-binding activity. Supershift assays with a STAT3 element probe demonstrated that nuclear factor kappaB (NF-kappaB) p65 and p50 complexed with STAT3 in the DNA-protein complex. The direct interaction of STAT3 and NF-kappaB p65 was verified in vivo by co-immunoprecipitation and in vitro by pull-down assays with glutathione S-transferase-NF-kappaB p65 fusion protein and in vitro -translated STAT3alpha. Overexpression of STAT3 dramatically inhibited IL-1beta- or LPS+IFN-gamma-mediated induction of iNOS promoter-luciferase constructs that contained the wild-type iNOS promoter or ones harbouring mutated STAT-binding elements. In tests of indirect inhibitory effects of STAT3, overexpression of STAT3 dramatically inhibited the activity of an NF-kappaB-dependent promoter devoid of STAT-binding elements without affecting NF-kappaB DNA-binding activity. Thus STAT3, via direct interactions with NF-kappaB p65, serves as a dominant-negative inhibitor of NF-kappaB activity to suppress indirectly cytokine induction of the iNOS promoter in mesangial cells. These results provide a new model for the termination of NO production by activated iNOS following exposure to pro-inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057007      PMCID: PMC1222853          DOI: 10.1042/BJ20020588

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins.

Authors:  T Decker; P Kovarik
Journal:  Cell Mol Life Sci       Date:  1999-09       Impact factor: 9.261

2.  Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription.

Authors:  C H Shen; J Stavnezer
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Stat5b inhibits NFkappaB-mediated signaling.

Authors:  G Luo; L Yu-Lee
Journal:  Mol Endocrinol       Date:  2000-01

4.  Inducible nitric oxide synthase can be induced in the absence of active nuclear factor-kappaB in rat mesangial cells: involvement of the Janus kinase 2 signaling pathway.

Authors:  O Nakashima; Y Terada; S Inoshita; M Kuwahara; S Sasaki; F Marumo
Journal:  J Am Soc Nephrol       Date:  1999-04       Impact factor: 10.121

5.  Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation.

Authors:  X Zhang; M H Wrzeszczynska; C M Horvath; J E Darnell
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  CCAAT/enhancer binding protein-beta trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line.

Authors:  A K Gupta; B C Kone
Journal:  Am J Physiol       Date:  1999-04

7.  alpha-MSH inhibits induction of C/EBPbeta-DNA binding activity and NOS2 gene transcription in macrophages.

Authors:  A K Gupta; R A Diaz; S Higham; B C Kone
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

8.  Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.

Authors:  B G Darnay; J Ni; P A Moore; B B Aggarwal
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

9.  Stat protein transactivation domains recruit p300/CBP through widely divergent sequences.

Authors:  M Paulson; S Pisharody; L Pan; S Guadagno; A L Mui; D E Levy
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

10.  p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.

Authors:  E Pfitzner; R Jähne; M Wissler; E Stoecklin; B Groner
Journal:  Mol Endocrinol       Date:  1998-10
View more
  109 in total

1.  γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents.

Authors:  Ramaswamy Kannappan; Vivek R Yadav; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

2.  β-Cell mass restoration by α7 nicotinic acetylcholine receptor activation.

Authors:  Dhananjay Gupta; Adam A Lacayo; Shane M Greene; John L Leahy; Thomas L Jetton
Journal:  J Biol Chem       Date:  2018-11-05       Impact factor: 5.157

3.  Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.

Authors:  Lei Shen; Ting Zhou; Jing Wang; Xiumei Sang; Lei Lan; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2017-04-13       Impact factor: 4.575

4.  Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells.

Authors:  Li Hou; Bo Xu; Wei Guo; Fu-Xiang Ran; Jing-Tao Liu; Xia Yuan; Hong-Zheng Fu; Jing-Rong Cui
Journal:  J Cancer Res Clin Oncol       Date:  2012-05       Impact factor: 4.553

5.  Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.

Authors:  Sahdeo Prasad; Manoj K Pandey; Vivek R Yadav; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

Review 6.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

7.  Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.

Authors:  Jung Ok Ban; Dae Hwan Kim; Hee Pom Lee; Chul Ju Hwang; Jung-Hyun Shim; Dae Joong Kim; Tae Myoung Kim; Heon-Sang Jeong; Seong Su Nah; Hanyong Chen; Zigang Dong; Young Wan Ham; Youngsoo Kim; Sang-Bae Han; Jin Tae Hong
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

9.  Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.

Authors:  Ajaikumar B Kunnumakkara; Asha S Nair; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 10.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.